TTK Healthcare Limited — Board Meeting, 21-03-2025: Outcome of Board Meeting

The Board has approved the redesignation of Mr. S Kalyanaraman as Managing Director & Chief Executive Officer, effective immediately until May 31, 2029, pending shareholder approval via postal ballot. The board also gave consent for the postal ballot process, appointing M/s A K Jain & Associates as Scrutinizer for a transparent voting process. This move aligns with the company's strategic direction and governance framework, ensuring continuity in leadership.